ProCE Banner Activity


Practical Case Studies in Outpatient COVID-19 Management


Hear faculty experts discuss case studies illustrating outpatient management of COVID-19, including a young healthy patient, an older patient with multiple comorbidities, a patient with an immunocompromising condition, and a patient needing evaluation in the emergency department.

Nurses: 1.00 Nursing contact hours, includes 1.00 hour of pharmacology credit (0.1 CEUs)

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit

Pharmacists: 1.00 contact hour (0.1 CEUs)

Released: December 15, 2022

Expiration: December 14, 2023

Begin Activity



Jason E. Farley

Jason E. Farley, PhD, MPH, ANP-BC, FAAN, AACRN

Endowed Professor of Nursing Leadership and Innovation
Johns Hopkins University School of Nursing
Director, Center for Infectious Disease and Nursing Innovation
Adult Nurse Practitioner, Infectious Diseases
Johns Hopkins Medicine
Baltimore, Maryland

Renslow Sherer

Renslow Sherer, MD

Director, International HIV Training Center
Professor of Medicine
Section of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


This activity is supported by educational grants from

Gilead Sciences, Inc.

Merck Sharp & Dohme Corp


Practicing Clinicians Exchange

ProCE Banner


ProCE Banner

Target Audience

This program is intended for physicians, nurse practitioners, nurses, pharmacists, and other healthcare professionals involved in the management of patients with COVID-19, including both specialists and primary care providers. This identified target audience will benefit from this education by gaining the knowledge and strategies necessary to individualize early outpatient COVID-19 management.

Program Learning Goal

The goal of this activity is to improve healthcare professionals’ knowledge and competence and foster an interprofessional approach for early SARS-CoV-2 diagnosis and treatment in the outpatient setting to mitigate severe and long-term consequences of COVID-19.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify candidates for early outpatient treatment with SARS-CoV-2 antivirals based on determinants associated with adverse outcomes, including risk factors for severe illness and health disparities

  • Select the appropriate antiviral treatment for patients with COVID-19 based on patient factors, guidelines, and current scientific evidence

  • Apply strategies to promote timely and equitable administration of SARS-CoV-2 antivirals


Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN, has no relevant financial relationships to disclose.

Renslow Sherer, MD: unrestricted research grant: Gilead Sciences.

The planners and content peer reviewers from Clinical Care Options, LLC, Practicing Clinicians Exchange, and ProCE, LLC, do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from December 15, 2022, through December 14, 2023:

1. Register online at
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 100% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.


This program has been made available online.


Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO), ProCE, LLC, and Practicing Clinicians Exchange. Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 


Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

Continuing Pharmacy Education

Credit Designation

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - JA4008176-0000-22-309-H01-P. 
Type of Activity: Application

Upon successfully completing the post-test with a score of 100% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.